The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(Pyrazine-2-carboxamido)-4'-(piperidin-4-yl)-[1,1'-biphenyl]-3-carboxylic acid ID: ALA4538561
PubChem CID: 155549217
Max Phase: Preclinical
Molecular Formula: C23H22N4O3
Molecular Weight: 402.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc(NC(=O)c2cnccn2)cc(-c2ccc(C3CCNCC3)cc2)c1
Standard InChI: InChI=1S/C23H22N4O3/c28-22(21-14-25-9-10-26-21)27-20-12-18(11-19(13-20)23(29)30)16-3-1-15(2-4-16)17-5-7-24-8-6-17/h1-4,9-14,17,24H,5-8H2,(H,27,28)(H,29,30)
Standard InChI Key: FSXSJQSLCYEKDE-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
25.3315 -4.5688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3304 -5.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0384 -5.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7481 -5.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7452 -4.5652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0366 -4.1599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0401 -6.6123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3307 -7.0201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3301 -7.8366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0382 -8.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7484 -7.8333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7455 -7.0183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0428 -9.0607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3337 -9.4688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3326 -10.2825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0390 -10.6941 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.7480 -10.2860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7508 -9.4662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4514 -4.1539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1607 -4.5599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.4483 -3.3368 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.6237 -4.1604 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.9161 -4.5691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2083 -4.1607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9163 -5.3863 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.2117 -3.3429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5048 -2.9346 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7962 -3.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7990 -4.1648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5065 -4.5695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
10 13 1 0
5 19 1 0
19 20 2 0
19 21 1 0
1 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 402.45Molecular Weight (Monoisotopic): 402.1692AlogP: 3.56#Rotatable Bonds: 5Polar Surface Area: 104.21Molecular Species: ZWITTERIONHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.84CX Basic pKa: 10.07CX LogP: -0.05CX LogD: -0.05Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.60Np Likeness Score: -1.07
References 1. Zhang Z, Hao K, Li H, Lu R, Liu C, Zhou M, Li B, Meng Z, Hu Q, Jiang C.. (2019) Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y14 receptor antagonists., 181 [PMID:31376563 ] [10.1016/j.ejmech.2019.111564 ]